Results 1 to 10 of about 19,151 (222)

A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City [PDF]

open access: yesHarm Reduction Journal, 2023
Background Since the emergence of fentanyl in the drug market, syringe services programs (SSPs) have been at the forefront of providing life-saving tools such as naloxone and fentanyl test strips to people who use drugs (PWUD).
Nisha Beharie   +2 more
doaj   +4 more sources

Is your syringe services program cost-saving to society? A methodological case study [PDF]

open access: yesHarm Reduction Journal, 2021
Background While there is a general acceptance among public health officials and policy-makers that syringe services programs can be effective in reducing HIV transmission among persons who inject drugs, local syringe services programs are often asked to
Don C. Des Jarlais   +4 more
doaj   +5 more sources

Application of machine learning algorithms for localized syringe services program policy implementation – Florida, 2017 [PDF]

open access: yesAnnals of Medicine, 2022
Background People who inject drugs (PWID) are at an amplified vulnerability for experiencing a multitude of harms related to their substance use, including viral (e.g. HIV, Hepatitis C) and bacterial infections (e.g. endocarditis).
Tyler S. Bartholomew   +3 more
doaj   +4 more sources

Implementation of low-dose buprenorphine induction at a syringe services program [PDF]

open access: yesAddiction Science & Clinical Practice
Background Fentanyl’s penetration into the unregulated drug supply has complicated the treatment of opioid use disorder (OUD), particularly by increasing the risk of buprenorphine-precipitated opioid withdrawal (BPOW).
Maia H. Hauschild   +11 more
doaj   +3 more sources

COVID-19 vaccine implementation at a syringe services program: experiences of frontline staff [PDF]

open access: yesBMC Health Services Research
Background While people with substance use disorders, including people who inject drugs (PWID), experience increased risk for COVID-19 infection and adverse outcomes, COVID-19 vaccination rates among PWID are consistently lower than those observed in the
Marina Plesons   +8 more
doaj   +4 more sources

Rapid initiation of antiretrovirals at a syringe services program for people with HIV who inject drugs [PDF]

open access: yesAnnals of Medicine
Background People who inject drugs (PWID) living with HIV are less likely to receive care at early disease stages and have low rates of viral suppression.
Marina Plesons   +11 more
doaj   +4 more sources

Syringe disposal among people who inject drugs before and after the implementation of a syringe services program [PDF]

open access: yesDrug and Alcohol Dependence, 2019
Due to the increase in people who use opioids in the US, there has been a steady increase in injection drug use. Without access to safe syringe disposal locations, people who inject drugs (PWID) have few options other than improper disposal, including in public places.
Hansel Tookes   +2 more
exaly   +5 more sources

Harm reduction self-efficacy and motivations for contactless supply access among a sample of syringe services program participants [PDF]

open access: yesHarm Reduction Journal
Background Contactless harm reduction supply methods (e.g., vending machines, mail order, mobile delivery) have become prevalent in the United States.
Rachel A. Hoopsick   +2 more
doaj   +2 more sources

Implementation and first-year operating costs of an academic medical center-based syringe services program [PDF]

open access: yesHarm Reduction Journal, 2021
Background Syringe services programs (SSPs) remain highly effective, cost-saving interventions for the prevention of blood-borne infections among people who inject drugs.
Tyler S. Bartholomew   +4 more
doaj   +2 more sources

Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes. [PDF]

open access: yesJ Addict Med, 2022
Objectives Low-threshold buprenorphine treatment aims to reduce barriers to evidence-based opioid use disorder treatment. We aimed to describe the treatment philosophy, practices, and outcomes of a low-threshold syringe services program (SSP)-based buprenorphine program developed through an SSP-academic medical center ...
Jakubowski A   +10 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy